Publications by authors named "Simon Haroutiunian"

Based on 19 studies (7,238 participants) a Cochrane review concludes that the addition of caffeine to an analgesic drug provides superior analgesia compared with the analgesic drug alone. The benefit is small, with a number needed to treat of approx. 16.

View Article and Find Full Text PDF

Persistent postsurgical pain (PPSP) is a frequent and often disabling complication of many surgical procedures. Nerve injury-induced neuropathic pain (NeuP) has repeatedly been proposed as a major cause of PPSP. However, there is a lack of uniformity in NeuP assessment across studies, and the prevalence of NeuP may differ after various surgeries.

View Article and Find Full Text PDF

Background: Methadone belongs to a class of analgesics known as opioids, that are considered the cornerstone of therapy for moderate-to-severe pain due to life-threatening illnesses; however, their use in chronic non-cancer pain (CNCP) is controversial. Methadone has many characteristics that differentiate it from other opioids, which suggests that it may have a different efficacy and safety profile.

Objectives: To assess the analgesic effectiveness and safety of methadone in the treatment of CNCP.

View Article and Find Full Text PDF

Chronic pain produces major functional disability and quality-of-life impairment. Monitoring of health-related quality of life (HRQoL) outcomes in chronic pain patients during treatment is of great importance. Nevertheless, monitoring individual chronic pain patients remains a challenge due to the lack of a validated and efficient HRQoL assessment instrument.

View Article and Find Full Text PDF

Objective: The aim was to characterize the transfer of the insulin analog glargine across the placenta using the placental perfusion model.

Methods: Placentas were obtained and selected cotyledons were cannulated and dually perfused. Glargine, 50 mU/L (n = 2) and 200 mU/L (n = 1), and a reference marker, antipyrine (50 μg/mL), were added to the maternal circulation.

View Article and Find Full Text PDF

Background: Depot formulations prolong the analgesic effect of local anesthetics and reduce peak plasma drug concentration. This allows for safer administration of larger doses of local anesthetics, which further prolongs the duration of analgesic effect. We previously reported the development of large multivesicular vesicles (LMVVs) remotely loaded with bupivacaine (LMVV liposomal bupivacaine) and demonstrated a >5-fold prolongation of analgesic effect in animals and humans.

View Article and Find Full Text PDF

Objective: Systematic reviews previously reported in the literature document that topical nonsteroidal anti-inflammatory drugs (NSAIDs) are effective in relieving pain in acute and chronic painful musculoskeletal disorders including osteoarthritis, tendonitis, and muscle strains. Because several topical NSAIDs are available, with important differences among the formulations, there is a need to address and summarize the evidence of their effectiveness and safety.

Design: We searched Medline and Cochrane CENTRAL databases for clinical trials and systematic reviews of topical NSAIDs in musculoskeletal pain, using the following keywords: "NSAID,""nonsteroidal,""antiinflammatory,""topical,""cream,""gel,""solution,""lotion,""patch,"plaster,""musculoskeletal,""tendonitis,""strain,""sprain,""trauma," and word roots "pain" and "arthritis.

View Article and Find Full Text PDF

Several case reports indicate that carbapenem antibiotics, especially meropenem, may decrease the plasma concentrations of valproic acid (VPA), thus decreasing its therapeutic activity. To investigate the onset, severity, and dose dependency of the interaction between meropenem and VPA, the authors carried out a retrospective evaluation of data collected during 24 months from patients hospitalized in a tertiary medical center. The analysis included 36 patients.

View Article and Find Full Text PDF

Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction. The complexity of the disease and its treatments make MG patients particularly susceptible to adverse effects of drugs. MG is not a painful condition; however, as pain management armamentarium includes drugs from diverse pharmacological groups and with potential for drug-drug interactions, managing pain in patients with MG can be challenging.

View Article and Find Full Text PDF
Article Synopsis
  • Cannabinoids have a long history of use for pain relief, and recent research focuses on their effectiveness in treating chronic pain conditions.
  • An open-label study with 13 patients suffering from chronic nonmalignant pain tested the impact of oral Delta-9-tetrahydrocannabinol (Delta-9-THC), revealing that 5 patients had a positive response, while 8 did not.
  • Most patients tolerated the treatment well, though some experienced adverse events, suggesting that while oral THC could benefit certain patients, more research is needed to identify those who would most likely respond to it.
View Article and Find Full Text PDF

Parkinson's disease (PD) is a progressive neurodegenerative, dopamine deficiency disorder. The main therapeutic strategies for PD treatment relies on dopamine precursors (levodopa), inhibition of dopamine metabolism (monoamine oxidase [MAO] B and catechol-O-methyl transferase inhibitors), and dopamine receptor agonists. Recently, a novel selective and irreversible MAO B propargylamine inhibitor rasagiline (N-propargyl-1-R-aminoindan, Azilect((R))) was approved for PD therapy.

View Article and Find Full Text PDF

Objective: The aim of the study was to quantify and characterize metformin transfer across the human placenta using an ex vivo placental perfusion model.

Study Design: Placentas were obtained from vaginal deliveries or caesarean sections and selected cotyledons were cannulated and dually perfused. Metformin (1 microg/ml) and a permeability reference marker, antipyrine (50 microg/ml), were added to the maternal circulation.

View Article and Find Full Text PDF